Global 7-Aminocephalosporanic Acid Key Players Rank and Market Share, Top 5 Companies Hold 54% (2022 (Internet Services - Other Internet Services)
INNetAds > Internet Services > Other Internet Services
Item ID 2872847 in Category: Internet Services - Other Internet Services
Global 7-Aminocephalosporanic Acid Key Players Rank and Market Share, Top 5 Companies Hold 54% (2022 | |
According to the new market research report “Global 7-Aminocephalosporanic Acid Market Report 2023-2029”, published by QYResearch, the global 7-Aminocephalosporanic Acid market size is projected to reach USD 1.02 billion by 2029, at a CAGR of 6.3% during the forecast period. According to QYResearch Top Players Research Center, the global key manufacturers of 7-Aminocephalosporanic Acid include Joincare Pharmaceutical, Sinopharm Weiqida Pharma, CSPC Pharma, Yili Chuannig Biotechnology, CordenPharma, etc. In 2022, the global top four players had a share approximately 48.0% in terms of revenue. Market Status: 7-ACA, also known as 7-aminocephalosporanic acid, is a key intermediate of cephalosporin (β-lactam) antibiotics, with the appearance of white crystalline powder. Cephalosporin antibiotics can inhibit the formation of cell walls, with a wide antibacterial spectrum, strong bactericidal effect, less allergic reactions and other advantages, is the largest clinical use of antibiotics category. A variety of cephalosporin antibiotics can be produced by utilizing 7-ACA, so 7-ACA has an important position in the antibiotic industry. 7-ACA can synthesize a variety of cephalosporin antibiotics, there are more than 30 kinds of common clinical cephalosporins, mainly cefazolin sodium, cefotaxime sodium, cefoperazone sodium, ceftazidime sodium, cefuroxime sodium, cefotriazin sodium, etc. Since the 21st century, with the continuous research and development of new products, the market demand for 7-ACA has been increasing. At this stage, in the global antibiotic market, the market share of cephalosporin antibiotics accounts for about 70%, in this context, 7-ACA market space is large. 7-ACA is prepared by biological fermentation, chemical refining method to obtain cephalosporin C, and then enzyme or chemical cleavage of cephalosporin C to produce 7-ACA. In comparison, the cost of chemical preparation of 7-ACA is higher, and the cost of enzyme preparation of 7-ACA is lower. 7-ACA production capacity in China was weak before the 21st century, and the demand for it mainly relied on imports. In the 21st century, China's 7-ACA production capacity has been expanding, mainly prepared by chemical method before 2010, after 2010, enzyme production capacity began to increase, and the overall production cost of the industry has been reduced. Since 2001, China's 7-ACA production capacity has been expanding, to around 2005, production capacity has been in excess, the price war competition is fierce, foreign enterprises have withdrawn from the domestic market,, Chinese enterprises are in an absolutely dominant position, before and after 2010,,, China's 7-ACA producers in large numbers. According to relevant surveys, during 2001-2020, affected by multiple factors such as overcapacity, demand growth, antibiotic price decline, tightening national regulation, environmental protection and so on, China's 7-ACA price fluctuation is large, and in the case of increasingly fierce competition in the market, one after another, enterprises have withdrawn from the market. At this stage, the main producers of 7-ACA in China are Chuanning Bio, Healthy Yuan, Shiyao Group, Wichida, etc., with a high degree of industry concentration. Although the number of 7-ACA producers in China has decreased after the elimination of the fittest, the phenomenon of overcapacity still exists, and the profitability of enterprises is limited. Due to competitive pressure and weak profitability, the scale of China's 7-ACA production capacity is still contracting, as can be seen by the contraction of 7-ACA production capacity by the leading enterprise, Coren Pharmaceuticals, although there is a large space in the 7-ACA market, due to the overcapacity, there is less room for the development of the industry, and the weaker enterprises as well as the new entrants do not have any potential for development. In the future, the pattern of China's 7-ACA market will continue to be stable, and the four leading companies, Chuanning Bio, Healthy Yuan, Shiyao Group and Vichyta, will monopolize the market. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.  | |
| Target State: All States Target City : All Cities Last Update : 15 April 2024 7:30 AM Number of Views: 77 | Item Owner : Joyce Contact Email: Contact Phone: 13051817187 |
| Friendly reminder: Click here to read some tips. | |
INNetAds > Internet Services > Other Internet Services
© 2024 INNetAds.com
USNetAds.com | GetJob.us | CANetAds.com | UKAdsList.com | AUNetAds.com | CNNetAds.com | Hot-Web-Ads.com | USAOnlineClassifieds.com
2024-11-21 (0.439 sec)